Cholinesterase (ChE), divided into two enzymes acetylcholinesterase (AChE) and butyrylcholinestarase (BChE), have been identified as potential targets in the treatment of AD, myasthenia gravis and glaucoma. Here, ACHE is linked to myasthenia gravis.